Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cullinan Therapeutics Inc (NASDAQ: CGEM) was $12.90 for the day, up 5.13% from the previous closing price of $12.27. In other words, the price has increased by $5.13 from its previous closing price. On the day, 0.74 million shares were traded. CGEM stock price reached its highest trading level at $12.95 during the session, while it also had its lowest trading level at $11.875.
Ratios:
Our analysis of CGEM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.46 and its Current Ratio is at 24.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 18 ’24 when Michaelson Jennifer sold 4,693 shares for $11.41 per share. The transaction valued at 53,547 led to the insider holds 99,760 shares of the business.
Jones Jeffrey Alan sold 4,632 shares of CGEM for $52,851 on Dec 18 ’24. The Chief Medical Officer now owns 114,059 shares after completing the transaction at $11.41 per share. On Dec 18 ’24, another insider, SUMER JACQUELYN L, who serves as the Chief Legal Officer of the company, sold 3,482 shares for $11.41 each. As a result, the insider received 39,730 and left with 90,651 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 751136000 and an Enterprise Value of 99808080.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $9.24. The 50-Day Moving Average of the stock is -8.60%, while the 200-Day Moving Average is calculated to be -27.48%.
Shares Statistics:
CGEM traded an average of 491.38K shares per day over the past three months and 499190 shares per day over the past ten days. A total of 58.14M shares are outstanding, with a floating share count of 37.06M. Insiders hold about 36.36% of the company’s shares, while institutions hold 77.32% stake in the company. Shares short for CGEM as of 1732838400 were 9157765 with a Short Ratio of 19.64, compared to 1730332800 on 9021016. Therefore, it implies a Short% of Shares Outstanding of 9157765 and a Short% of Float of 18.23.
